Page 3 - Best Metastases in the liver doctors: TOP 84 doctors

Prof. Wolfgang Köstler specializes in personalized cancer medicine, with a focus on breast and gynecologic malignancies. His work in targeted therapies helps tailor treatments for better outcomes.

• Over 22 years of experience of experience in medical oncology
• Former Deputy Head of Oncology at Medical University of Vienna
• Expert in biomarker development and tumor biology
• Senior consultant at Wiener Privatklinik
• Active in European oncology networks and clinical trials

Univ. Prof. Dr. Klaus Kaczirek is a leading expert in endocrine and oncologic surgery, specializing in thyroid, parathyroid, and adrenal gland procedures.

• Over 25 years of experience of experience in endocrine and visceral surgery
• Professor of Surgery at Medical University of Vienna
• Specializes in neuroendocrine tumors and hormone-producing cancers
• Published extensively on endocrine tumor biology and minimally invasive techniques

Associate Professor Tahsin Ozatli specializes in breast, lung, and gastrointestinal cancers at Istinye Liv University Hospital.

• Over a decade of experience in oncology
• Worked at Ankara Oncology Clinic and Erzurum Regional Training and Research Hospital
• Promoted to Associate Professor in 2016

Specialized in laparoscopic surgery for liver metastases – trained at Istanbul University's top programs.

• Over 16 years of experience in general and laparoscopic surgery
• Advanced training in laparoscopic bariatric and oncological cancer surgery
• Member of the Turkish Surgical Association

Assoc. Prof. Nail Paksoy specializes in liver metastases treatment at Medipol Bahçelievler Hospital, with extensive research in oncology.

• ESMO Board Certified in Medical Oncology
• Participated in multiple international clinical trials for cancer treatments
• Published numerous articles on metastatic cancers
• Fellowship-trained at Istanbul University Oncology Institute

Professor Gul Alco combines 31 years of experience of radiation oncology experience with academic leadership at top Turkish universities.

• Specialized in liver metastasis treatment using precise radiation techniques
• Professor at Istanbul Medipol University's Radiation Oncology Department
• Trained at Istanbul University – Turkeys leading medical school
• Balances clinical practice with teaching future radiation oncologists

Specialized in Medical Oncology with training at Akdeniz University – Dr. Alemdar focuses on liver metastases at Medical Park Antalya.

• Trained in Internal Medicine before specializing in oncology
• Experience across multiple top hospitals including Akdeniz University
• Current role at Medical Park Antalya Hospital Complex
• Member of professional oncology associations

49 years of experience specializing in virotherapy – Dr. Jaunalksne brings cutting-edge immunological approaches to liver metastases at Pallas Clinic.

• Head of Clinical Immunology Center at Pauls Stradins Clinical University Hospital
• Graduate of Riga Medical Institute with internship in Internal Medicine
• Focuses on innovative immunotherapy treatments

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

Dr. Mariam Mohammed Hussein Abu Zeid is a clinical oncologist. She treats solid tumors and hematologic cancers. She earned her MBBCh from Ain Shams University in 2007 (Excellent). She completed a Master’s in Clinical Oncology and Nuclear Medicine in 2011 (Very Good). She received a Ph.D. in 2018 and an ESMO Certificate in 2015.

She leads and monitors clinical trials. Her work includes data collection and analysis. She administers chemotherapy and manages treatment toxicities. She also plans care with multidisciplinary teams. Her experience includes Ain Shams University Hospitals (2009–2012), the International Medical Center (2012–2014), and Wadi El Nile Hospital (2015–2019). Her roles covered diagnosis and staging, supportive care, quality improvement, and screening. She educates patients and families about the diagnosis, treatment options, and palliative care.

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

Prof. Ben Boursi is a physician in the Gastrointestinal Cancer Department at Sheba Medical Center. He specializes in internal medicine, medical oncology, and cancer epidemiology. He is board certified in internal medicine and medical oncology. He earned a B.Med.Sc (summa cum laude) and an MD (magna cum laude) from Tel Aviv University.

He completed clinical and research fellowships in GI oncology and cancer epidemiology at the University of Pennsylvania. He also completed electives at MD Anderson and Mayo Clinic. He founded the ECOG-ACRIN Microbiome Working Group. His microbiome-oncology research has been published in leading journals, including Science, and highlighted by ASCO.

He developed predictive models for early diagnosis of colorectal and pancreatic cancers. These models are now in clinical evaluation. He holds an academic appointment at Tel Aviv University. He is also an Associate Scholar at the University of Pennsylvania.

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.

Specializes in complex cancer surgeries, including liver metastases, at Büyük Anadolu Hospitals.

• Expert in pancreatic and bile duct surgeries
• Skilled in oncological and breast surgeries
• Experienced in gastric and colon cancer procedures
• Performs thyroid cancer and obesity surgeries

Dr. Maha Yahia is a medical oncologist and hemato-oncologist. She provides assessment, diagnosis, and treatment planning. Her treatments include chemotherapy, targeted therapy, and immunotherapy. She cares for patients with breast, genitourinary, gynecologic, thoracic, gastrointestinal, and rare cancers.

Education: M.B.B.Ch, Kasr El-Aini, Cairo University (1997–2003). Master in Hemato-oncology, National Cancer Institute, Cairo University (2008). Doctoral Degree in Hemato-oncology, National Cancer Institute, Cairo University (2015).

Experience: Resident in Medical Oncology, Maadi AFMC (2005–2010). Visitor Resident, NCI Cairo (2008–2009). Consultant Assistant, Prof. Hussein Khaled Clinic (2010–2017). Specialist, International Medical Center (2011–2012), Wadi El Nile Hospital (2013–2014), and Maadi AFMC (2011–2018). Head, Clinical Research Support Team, Maadi AFMC (2016–2018). Major (2014–2016) and Lt. Colonel Doctor (2016–2018), Egyptian Armed Forces. Lecturer of Clinical Research, AFCM (2019–2021).

Dr. Yaacov Lawrence, MA, MBBS, MRCP, is Chair of Radiation Oncology at Sheba Medical Center. He has nearly 30 years of experience in precision radiation oncology and neuro-oncology.

He is an expert in advanced radiation therapy and radiosurgery. He performs stereotactic radiosurgery for brain tumors. He leads Sheba’s GI Cancer Program in gastrointestinal oncology. He also provides precision care for lung and prostate cancers. He pioneered celiac plexus radiosurgery for severe pain from pancreatic cancer.

Training and credentials: MA and MBBS (Cambridge and UCLH); MRCP (RCP); Radiation Oncology fellowship (Thomas Jefferson University). Honors include the ASCO Young Investigator Award and Fellow of ASTRO (FASTRO). He has authored over 280 publications. He is Director of the Center for Translational Radiation Oncology and an Associate Professor at Tel Aviv University.

Professor Rifaat Safadi leads the liver disease unit at Hadassah Medical Center, specializing in advanced liver treatments with international recognition.

• Trained under Professor Scott Friedman at Sinai School of Medicine in New York
• Member of international liver study associations
• Awarded for research on immune modulation of liver fibrosis
• Author of numerous articles in hepatology
• Head of liver disease unit at Hadassah Medical Center